MetaVia (MTVA) Other Operating Expenses (2015 - 2026)
MetaVia's (MTVA) quarterly Other Operating Expenses came in at -$381000.0 in Q4 2025, down 36.07% YoY from -$595977.7 in Q4 2024, and down 74.77% on a QoQ basis from -$218000.0 in Q3 2025.
MetaVia (MTVA) Other Operating Expenses (2015 - 2026) Analysis & Trends
MetaVia (MTVA) has 4 years of Other Operating Expenses data on file, last reported at -$381000.0 in Q4 2025.
- Quarterly Other Operating Expenses fell 36.07% year-over-year to -$381000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$948000.0 (down 11.27% YoY) and the FY2025 annual result came in at -$948000.0, up 22.36% from the prior year.
- Other Operating Expenses fell to -$381000.0 in Q4 2025, from -$218000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $8.2 million in Q4 2022 to a low of -$7.6 million in Q3 2022.
- A 3-year average of -$136555.6 and a median of -$223000.0 in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 37.54% in 2025, down 36.07% in 2025.
- Tracing MTVA's Other Operating Expenses over 3 years: stood at $8.2 million in 2022, then tumbled by 103.41% to -$280000.0 in 2024, then plunged by 36.07% to -$381000.0 in 2025.
- The last three Other Operating Expenses figures came in at -$381000.0 (Q4 2025), -$218000.0 (Q3 2025), and -$141000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -247,000.00 |
| Dec 31, 2025 | -381,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | -141,000.00 |
| Mar 31, 2025 | -208,000.00 |
| Dec 31, 2024 | -280,000.00 |
| Sep 30, 2024 | -349,000.00 |
| Jun 30, 2024 | -223,000.00 |
| Dec 31, 2022 | 8.21 Mn |
| Sep 30, 2022 | -7.64 Mn |
| Mar 31, 2015 | 908,000.00 |